Visualitza per autor "Rodon Ahnert, Jordi"
Ara mostrant els elements 1-13 d 13
-
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights
Elez Fernandez, Mª Elena; Argilés Martinez, Guillem; Matos Garcia, Ignacio; Sanz Garcia, Enrique; Macarulla Mercadé, Teresa; Alsina Maqueda, Maria; Sauri Nadal, Tamara; Verdaguer Mata, Helena; Viaplana Donato, Cristina; García Palmer, Héctor; Nuciforo, Paolo Giovanni; Rodon Ahnert, Jordi; Vivancos Prellezo, Ana; Tabernero Caturla, Josep; Capdevila Castillon, Jaume; Landolfi, Stefania; Ruiz Pace, Fiorella; Ortiz Velez, Carolina; Dienstmann, Rodrigo (Wiley, 2017-06-15) -
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor
Harding, James J.; Tan, Daniel S. W.; Bedard, Philippe L.; Rodon Ahnert, Jordi; Doi, Toshihiko; Bauer, Todd (Springer, 2019-04-15) -
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Garralda Cabanas, Elena; Aguilar, Susana; Sala De Vedruna, Gemma; Viaplana Donato, Cristina; González-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Mancuso, Francesco Mattia; Fasani, Roberta; Jiménez Flores, José Antonio; Martinez, Paola; Oaknin Benzaquen, Ana Mazaltob; Antunes de Melo Oliveira, Ana Mafalda; Balmaña Gelpí, Judith; Carles Galceran, Joan; Macarulla Mercadé, Teresa; Elez Fernandez, Mª Elena; Alsina Maqueda, Maria; Braña Garcia, Irene; Felip Font, Enriqueta; Tabernero Caturla, Josep; Rodon Ahnert, Jordi; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Ramos Masdeu, Laia; Saura Manich, Cristina; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (American Society of Clinical Oncology, 2020-05-14) -
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study
Pernas, Sonia; Villagrasa, Patricia; Vivancos Prellezo, Ana; Scaltriti, Maurizio; Rodon Ahnert, Jordi; Burgués, Octavio; Nuciforo, Paolo Giovanni; Antunes de Melo Oliveira, Ana Mafalda (Frontiers Media, 2021-11-04) -
First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours
Martín Liberal, Juan Jesús; Hollebecque, Antoine; Jungels, Christiane; Martin-Romano, Patricia; Rodon Ahnert, Jordi; Aftimos, Philippe (Springer Nature, 2020-10) -
Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity
Wright, Sarah Christine Elisabeth; Vasilevski, Natali; Serra Elizalde, Violeta; Rodon Ahnert, Jordi; Eichhorn, Pieter Johan Adam (MDPI, 2021-04) -
New clinical trial designs in the era of Precision Medicine
Garralda Cabanas, Elena; Piris Giménez, Alejandro; Braña Garcia, Irene; Rodon Ahnert, Jordi; Tabernero Caturla, Josep; Dienstmann, Rodrigo (Wiley Open Access, 2019-01-30) -
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma
Wick, Antje; Desjardins, Annick; Suárez Rodríguez, Cristina; Forsyth, Peter; Gueorguieva, Ivelina; Burkholder, Tiana; Rodon Ahnert, Jordi (Springer, 2020-10) -
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Garrido-Castro, Ana Christina; Barroso-Sousa, Romualdo; Guo, Hao; Ciruelos, Eva; Bermejo, Begoña; Serra Elizalde, Violeta; Rodon Ahnert, Jordi; Saura Manich, Cristina (BMC, 2020-11-02) -
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Matos Garcia, Ignacio; Hierro Carbó, Cinta; Martín Liberal, Juan Jesús; Berche, Roger; Pedrola Gómez, Anna; Braña Garcia, Irene; Azaro Pedrazzoli, Analía Beatriz; Vieito Villar, Maria; Saavedra Gadea, Omar; Gardeazabal, Itziar; Hernando Calvo, Alberto; Alonso-Casal, Guzman; Galvao De Aquiar, Vladimir; Ochoa de Olza Amat, Maria; Ros Montañá, Fco. Javier; Viaplana Donato, Cristina; Elez Fernandez, Mª Elena; Rodon Ahnert, Jordi; Macarulla Mercadé, Teresa; Oaknin Benzaquen, Ana Mazaltob; Carles Galceran, Joan; Felip Font, Enriqueta; Tabernero Caturla, Josep; Garralda Cabanas, Elena; Villacampa Javierre, Guillermo; Saura Manich, Cristina; Muñoz Couselo, Eva; Dienstmann, Rodrigo (Elsevier, 2021-09) -
Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
Wen, Patrick Yung; Rodon Ahnert, Jordi; Mason, Warren; Beck, Joseph T; DeGroot, John; Donnet, Valerie (BMJ, 2020-07) -
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours
Bono, Petri; Massard, Christophe; Peltola, Katriina J; Azaro Pedrazzoli, Analía Beatriz; Italiano, Antoine; Kristeleit, Rebecca S; Rodon Ahnert, Jordi (BMJ, 2020-12) -
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
Tamborero, David; Haj Rachid, Maan; Boekel, Jorrit; Lopez Fernandez, Adrià; Jonsson, Markus; Braña Garcia, Irene; Balmaña Gelpí, Judith; Villalobos Alberú, Xenia; Chavarria, Elena; Garralda Cabanas, Elena; Tabernero Caturla, Josep; Rodon Ahnert, Jordi; Dienstmann, Rodrigo (Nature Research, 2022-02)